Keyphrases
1-year Mortality
5%
30-day Mortality
5%
Acute Myocardial Infarction
100%
Alteplase
10%
Angina
6%
Angioplasty
6%
Baseline Characteristics
11%
Clinical Characteristics
7%
Clinical Outcomes
6%
Confidence Interval
10%
Coronary Angiography
6%
Coronary Angioplasty
6%
Coronary Artery
9%
Elderly Patients
5%
GUSTO
24%
Heparin
19%
Hospital Mortality
6%
Improved Survival
5%
Infarct
5%
Infarction
10%
Intracranial Hemorrhage
5%
Ischemia
6%
Israel
11%
Israeli
5%
Mobile Intensive Care Unit
6%
Mortality Rate
13%
Myocardial Infarction
12%
Odds Ratio
13%
Patency
8%
Patient Management
6%
Prognostic Significance
5%
Recombinant Tissue Plasminogen Activator (rt-PA)
24%
Reinfarction
15%
Revascularization
5%
ST Depression
7%
ST Elevation
10%
ST-segment Elevation
6%
Streptokinase
36%
Symptom Onset
8%
Thrombolysis
19%
Thrombolytic Therapy
69%
Tissue Plasminogen Activator (t-PA)
31%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
82%
Alteplase
22%
Anterior Myocardial Infarction
5%
Brain Hemorrhage
6%
Cerebrovascular Accident
9%
Fibrinolytic Agent
62%
Heart Infarction
15%
Heparin
19%
Hospital Mortality
12%
Infarction
18%
Inferior Myocardial Infarction
5%
Ischemia
9%
Mortality Rate
14%
Streptokinase
32%
Tissue Plasminogen Activator
25%
Medicine and Dentistry
Acute Heart Infarction
56%
Alteplase
13%
Angioplasty
8%
Anterior Myocardial Infarction
5%
Apoplexy
7%
Blood Clot Lysis
14%
Cerebral Hemorrhage
6%
Coronary Angiography
5%
Coronary Artery
5%
Elderly Patient
5%
Electrocardiogram
12%
Fibrinolytic Therapy
35%
Heparin
7%
Infarction
12%
Inferior Myocardial Infarction
9%
Intensive Care Unit
6%
Mortality Rate
6%
Myocardial Infarction
5%
Odds Ratio
7%
Q Wave
6%
Revascularization
5%
ST Elevation
7%
ST Segment Depression
7%
Streptokinase
9%
Thrombolytic Drug
11%
Tissue Plasminogen Activator
10%
Transluminal Coronary Angioplasty
8%